SEC Questions Musk’s Timing on Twitter Deal

July 15, 2022 by Madeline Hughes
SEC Questions Musk’s Timing on Twitter Deal
Elon Musk, Tesla CEO, attends the opening of the Tesla factory, Berlin-Brandenburg, in Grünheide, Germany, March 22, 2022. (Patrick Pleul/Pool via AP)

WASHINGTON — The U.S. Securities and Exchange Commission began to question Elon Musk about his potential attempt to pull out of his $44 billion deal to buy Twitter more than a month before he made it official.

The questions came after a May tweet in which Musk said his deal to buy the company was “on hold,” according to a letter dated June 2 released by the SEC Thursday. Staff from the commission had a phone call with Musk and his lawyers the day after the tweet, which they then followed up with the letter.

The letter states, “We note that on May 17, 2022, Elon R. Musk referred to the pending acquisition of Twitter, Inc. and publicly stated via his Twitter feed that ‘[t]his deal cannot move forward’. The term ‘cannot’ suggests that Mr. Musk and his affiliates are exercising a legal right under the terms of the merger agreement to suspend completion of the acquisition of Twitter or otherwise do not intend to complete the acquisition. Yet, we note that the Schedule 13D has not been amended to reflect the apparent material change that has occurred to the facts previously reported under Item 4 of Schedule 13D.”

The SEC asked for Musk to “Provide us with a written analysis in support of any conclusion that an amendment is not required” and also “Include in this analysis a clear statement as to Mr. Musk’s current plans or proposals with respect to the acquisition of Twitter. If a material change has occurred, then promptly amend the Schedule 13D.” 

In a letter filed June 7, Musk’s lawyer, Mike Ringler, said the tweet didn’t amount to him backing out of the deal.

“Despite Mr. Musk’s desire to obtain information to evaluate the potential spam and fake accounts, there was no material change to Mr. Musk’s plans and proposals regarding the proposed transaction at such time,” Ringler wrote.

Since Musk began his attempted takeover there have been questions about his filings. On April 4, the day Musk first disclosed a 9.2% stake in the company, the SEC wrote a letter to Musk asking why he didn’t file his Schedule 13G when he acquired 5% of the company’s stock on March 14.

According to SEC rules, he was required to make that disclosure by March 24 — 10 days after he reached the 5% threshold. The commission publicly posted that letter in May.

Twitter also raised concerns about how Musk purchased the shares in the lawsuit the company filed this week that seeks to hold him to his purchase agreement.

Twitter has asked that an expedited trial take place this September.

Madeline can be reached at [email protected] or on Twitter @ByMaddieHughes

A+
a-
  • Elon Musk
  • Securities and Exchange Commission
  • Twitter
  • In The News

    Health

    Voting

    Regulation

    March 26, 2024
    by Dan McCue
    Consumers Warned to Avoid Certain Topical Pain Relief Products 

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed... Read More

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed for topical use before, during or after certain cosmetic procedures. The warning came after the agency issued warning letters to six companies for marketing these products... Read More

    March 21, 2024
    by Dan McCue
    DOJ, 16 States Sue Apple Over Alleged Smartphone Monopoly

    WASHINGTON — The Justice Department and 16 state attorneys general sued Apple on Thursday accusing the Cupertino, California-based tech giant... Read More

    WASHINGTON — The Justice Department and 16 state attorneys general sued Apple on Thursday accusing the Cupertino, California-based tech giant of operating an illegal monopoly in the smartphone market. According to the lawsuit, which was filed in federal court in New Jersey, Apple has used the... Read More

    Trump Suggests He'd Support a National Ban on Abortions Around 15 Weeks of Pregnancy

    NEW YORK (AP) — Donald Trump suggested Tuesday that he’d support a national ban on abortions around 15 weeks of pregnancy, voicing... Read More

    NEW YORK (AP) — Donald Trump suggested Tuesday that he’d support a national ban on abortions around 15 weeks of pregnancy, voicing for the first time support for a specific limit on the procedure. The Republican former president has taken credit for striking down a federally guaranteed right... Read More

    March 15, 2024
    by Dan McCue
    EPA Sets Tougher Limits on Gas Used to Sterilize Medical Devices

    WASHINGTON — The Environmental Protection Agency on Thursday finalized tougher restrictions on ethylene oxide, a cancer-causing gas commonly used to... Read More

    WASHINGTON — The Environmental Protection Agency on Thursday finalized tougher restrictions on ethylene oxide, a cancer-causing gas commonly used to sterilize medical devices. The new standards specifically target commercial sterilization facilities. The agency called them “the strongest measures in U.S. history to reduce emissions of EtO,”... Read More

    March 15, 2024
    by Dan McCue
    EPA Proposes New Limits on Gas Distribution Facilities

    WASHINGTON — The Environmental Protection Agency on Thursday finalized a rule strengthening toxic air pollution standards at gasoline distribution facilities,... Read More

    WASHINGTON — The Environmental Protection Agency on Thursday finalized a rule strengthening toxic air pollution standards at gasoline distribution facilities, including storage tanks, loading operations and equipment leaks.  The action — from which gas stations are exempt — is expected to reduce emissions of air toxics,... Read More

    March 13, 2024
    by Dan McCue
    FDA Believed Poised to Approve First Med for a Serious Liver Disease

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious... Read More

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious liver disease known as MASH later this week.  Metabolic dysfunction-associated steatohepatitis -- formerly known as nonalcoholic steatohepatitis — is often associated with obesity. In patients who... Read More

    News From The Well
    scroll top